Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 4:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 137 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: SHIELD Clear all

Conditions: Suicidality
Interventions: accelerated Thetaburst stimulation, Sham Comparator; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2029
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: IgA Nephropathy (IgAN), Renal and Urinary Disorders, Berger Disease
Interventions: Atacicept 150 mg; Drug
Lead sponsor: Vera Therapeutics, Inc.; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 1
States / cities: Brisbane, California

Conditions: Intracranial Aneurysm
Interventions: Treatment of Intracranial Aneurysms; Device
Lead sponsor: Medtronic Neurovascular Clinical Affairs; Industry
Eligibility: 22 Years and older
Enrollment: 118 participants
Timeline: 2025 – 2033
U.S. locations: 10
States / cities: Jacksonville, Florida • Marietta, Georgia • Evanston, Illinois + 7 more

Conditions: Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma, Esophageal Carcinoma, Gastric Carcinoma, Liver Carcinoma, Lung Carcinoma, Malignant Solid Neoplasm, Ovarian Carcinoma, Pancreatic Carcinoma, Prostate Carcinoma
Interventions: Biospecimen Collection, Device Usage, Electronic Health Record Review, Multi-Cancer Early Detection Test, Questionnaire Administration; Procedure · Device · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 45 Years to 75 Years
Enrollment: 24,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 46
States / cities: Pleasanton, California • San Diego, California • Cheyenne Wells, Colorado + 38 more

Conditions: Gastroparesis
Interventions: Enterra HDE; Device
Lead sponsor: Methodist Health System; Other
Eligibility: 18 Years to 70 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2025
U.S. locations: 1
States / cities: Richardson, Texas

Conditions: Diabetes Mellitus Type 2
Interventions: Shared Decision Making; Behavioral
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 1,400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Fanconi Anemia
Interventions: Hematopoietic Stem Cell Transplant, Thymic Shielding During Radiation, Total Body Irradiation, Cyclophosphamide, Fludarabine; Procedure · Drug
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 1 Day to 18 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Skin Care
Interventions: Retinol Complex 0.5, Facial cleanser, Moisturizing lotion, Sunscreen, Skin Imaging; Other · Device
Lead sponsor: Allergan; Industry
Eligibility: 40 Years to 70 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Irvine, California

Conditions: Radiation Exposure to Operator
Interventions: Board, No Board; Device
Lead sponsor: Geisinger Clinic; Other
Eligibility: 18 Years to 89 Years
Enrollment: 265 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Patent Ductus Arteriosus in Premature Infants
Interventions: Chest shield with aluminum foil (CALF), SHIELD; Device
Lead sponsor: University of Rochester; Other
Eligibility: 23 Weeks to 33 Weeks
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Computed Tomography, Radiation Dosage
Interventions: Chrysalis breast displacement device; Device
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Dry Eye Disease, Meibomian Gland Dysfunction
Interventions: Protection of eyes with tinted soft scleral eye shields; Combination Product
Lead sponsor: Lumenis Be Ltd.; Industry
Eligibility: 22 Years to 120 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Colo-rectal Cancer
Interventions: Shield Blood Test for colo-rectal cancer Screening; Diagnostic Test
Lead sponsor: Guardant Health, Inc.; Industry
Eligibility: 45 Years to 81 Years
Enrollment: 3,375 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2030
U.S. locations: 60
States / cities: Chandler, Arizona • Gilbert, Arizona • Anaheim, California + 52 more

Conditions: Huntington Disease
Interventions: Not listed
Lead sponsor: CHDI Foundation, Inc.; Other
Eligibility: 18 Years to 63 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 5
States / cities: San Diego, California • Englewood, Colorado • Boston, Massachusetts + 2 more

Conditions: Snoring, Mouth Breathing, Daytime Sleepiness, Periodontitis
Interventions: Oral appliance therapy plus scaling and root planing on left or right of mouth; Device
Lead sponsor: Texas A&M University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Attention Deficit Disorder With Hyperactivity (ADHD)
Interventions: Transcranial Magnetic Stimulation (TMS), Sham Transcranial Magnetic Stimulation (Sham TMS); Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Sickle Cell Disease
Interventions: Alemtuzumab, low dose total body irradiation, Sirolimus; Drug
Lead sponsor: Robert Nickel; Other
Eligibility: 2 Years to 25 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2030
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Chicago, Illinois • New York, New York + 2 more

Conditions: Hypereosinophilic Syndrome
Interventions: dupilumab; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Suicide, Mental Disorder, Mental Health, Burnout, Professional, Self Harm
Interventions: SAFE Spaces training and coaching; Behavioral
Lead sponsor: New York University; Other
Eligibility: Not listed
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Pelvic Pain, Pelvic Floor Dysfunction, Voiding Dysfunction
Interventions: Home Pelvic Floor Trainer; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 8 Years to 18 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Burn Wounds - Partial Thickness (2nd Degree)
Interventions: Field Shield Wound Dressing, Silverlon; Device
Lead sponsor: KeriCure Medical; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Phoenix, Arizona • San Antonio, Texas

Conditions: Tick Bites, Tick-borne Diseases
Interventions: Permethrin Impregnated Clothing; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 135 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Kingston, Rhode Island

Conditions: Staphylococcus Aureus Infection
Interventions: Mupirocin + Nozin + chlorhexidine gluconate, Education + Household supplies; Combination Product · Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Whiteriver, Arizona

Conditions: Radiation Exposure
Interventions: Standard PPE, Texray PPE; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Atlanta, Georgia

Search by objective public record fields.

acTBS Treatment for Inpatient Subjects With Suicidality

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept

NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study

The Vanguard Study: Testing a New Way to Screen for Cancer

Medtronic Enterra II Neurostimulator

ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus

Stem Cell Transplantation for Fanconi Anemia

Study to Assess the Cosmetic Changes in the Facial Skin After Use of a Topical Retinoid Product in Participants With Moderate to Severe Photodamage

Physician Radiation Exposure During Radial Access Cardiac Catheterization Using a RAD Board

Chest Shielding in Premature Infants During Phototherapy

Breast Displacement and CT Radiation Dose

Safety of Tinted Soft Scleral Eye Shields When IPL is Applied on Eyelids

Shield Post-Approval Study Protocol

Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD

Does myTAP Oral Appliance Therapy Including a Mouth Shield Lessen Periodontitis in Mouth-Breathers Who Snore?

Transcranial Magnetic Stimulation for Attention Deficit/Hyperactivity Disorder (ADHD)

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents

Systems Aligning for Equity (SAFE) Spaces

HOme PElvic Floor Improvement Trainer Trial

Field Shield Wound Dressing Study

Tick-borne Illness and Clothing Study of Rhode Island

Staph Intervention for Effective Local Defense

Clinical Evaluation of a Novel Textile Radiation Protection Device